Targeting Human B-Cell Malignancies Through Ig Light Chain-Specific Cytotoxic T Lymphocytes

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-11-0970
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Dual T Cell Receptor Beta Chain Expression on Human T Lymphocytes

Journal of Experimental Medicine
MedicineAllergyImmunology
1995English

Ig Light Chain Receptor Editing in Anergic B Cells

Journal of Immunology
AllergyImmunology
2000English

Targeting of B-Cell Receptor Signalling in B-Cell Malignancies

Journal of Internal Medicine
Internal Medicine
2017English

A Dual Targeting Car-T Cell Approach for the Treatment of B Cell Malignancies

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Activation of Cytotoxic T-Cell Receptor T Lymphocytes in Response to Specific Stimulation in Myelodysplastic Syndromes

Haematologica
Hematology
2008English

Cytotoxic Lymphocytes in B-Cell Chronic Lymphocytic Leukemia

Annals of Hematology
MedicineHematology
1990English

Trans-Chromosomal Recombination Within the Ig Heavy Chain Switch Region in B Lymphocytes

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1998English

Targeting the 4-1bb Costimulatory Molecule Through Single Chain Antibodies Promotes the Human T-Cell Response

Cellular and Molecular Biology Letters
BiochemistryCell BiologyMolecular Biology
2020English

Combining CD19 Redirection and Alloanergization to Generate Tumor-Specific Human T Cells for Allogeneic Cell Therapy of B-Cell Malignancies

Cancer Research
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy